ArticleFrontiers in immunology2024

Preclinical characterization of MTX-101: a novel bispecific CD8 Treg modulator that restores CD8 Treg functions to suppress pathogenic T cells in autoimmune diseases.

Jennifer L Gardell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.